
Sign up to save your podcasts
Or


In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas. They discuss how parp inhibitors work and how they have come into play with gynecologic oncology, including how to discuss parp inhibitors with patients, recommendations for patient monitoring and follow up, and the future of ovarian cancer treatment.
By BMJ Group5
2323 ratings
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas. They discuss how parp inhibitors work and how they have come into play with gynecologic oncology, including how to discuss parp inhibitors with patients, recommendations for patient monitoring and follow up, and the future of ovarian cancer treatment.

37 Listeners

52 Listeners

5 Listeners

8 Listeners

5 Listeners

3 Listeners

2 Listeners

3 Listeners

8 Listeners

38 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

14 Listeners

3 Listeners

3 Listeners

23 Listeners